Chemotherapy-related cognitive impairment in older patients with cancer Journal Article


Authors: Loh, K. P.; Janelsins, M. C.; Mohile, S. G.; Holmes, H. M.; Hsu, T.; Inouye, S. K.; Karuturi, M. S.; Kimmick, G. G.; Lichtman, S. M.; Magnuson, A.; Whitehead, M. I.; Wong, M. L.; Ahles, T. A.
Article Title: Chemotherapy-related cognitive impairment in older patients with cancer
Abstract: Chemotherapy-related cognitive impairment (CRCI) can occur during or after chemotherapy and represents a concern for many patients with cancer. Among older patients with cancer, in whom there is little clinical trial evidence examining side effects like CRCI, many unanswered questions remain regarding risk for and resulting adverse outcomes from CRCI. Given the rising incidence of cancer with age, CRCI is of particular concern for older patients with cancer who receive treatment. Therefore, research related to CRCI in older patients with cancers is a high priority. In this manuscript, we discuss current gaps in research highlighting the lack of clinical studies of CRCI in older adults, the complex mechanisms of CRCI, and the challenges in measuring cognitive impairment in older patients with cancer. Although we focus on CRCI, we also discuss cognitive impairment related to cancer itself and other treatment modalities. We highlight several research priorities to improve the study of CRCI in older patients with cancer. © 2016 Elsevier Inc.
Keywords: chemotherapy; older patients; cancer treatment; cognitive impairment; research gaps
Journal Title: Journal of Geriatric Oncology
Volume: 7
Issue: 4
ISSN: 1879-4068
Publisher: Elsevier Inc.  
Date Published: 2016-07-01
Start Page: 270
End Page: 280
Language: English
DOI: 10.1016/j.jgo.2016.04.008
PROVIDER: scopus
PMCID: PMC4969145
PUBMED: 27197918
DOI/URL:
Notes: Review -- Export Date: 1 November 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tim A Ahles
    182 Ahles
  2. Stuart Lichtman
    228 Lichtman